Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0000950170-25-034650

SVP, General Counsel&Secretary sold 2,793 shares at $6.29 ($17,568)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Mano Michael SVP, General Counsel&Secretary 2025-03-04 Sale −2,793 $6.29 $17,568 21,047 D: show line 1 in the form
Open-market sales · 2,793 sh · avg $6.29 · $17,568
Loading xslF345X05/ownership.xml…